Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Pembrolizumab with chemoradiation therapy vs placebo plus CRT for locally advanc...
Prof Jean-Pascal Machiels - Cliniques Universitaires Sain-Luc, Brussels, Belgium
Pembrolizumab with chemoradiation therapy vs placebo plus CRT for locally advanced head and neck squamous cell carcinoma ( Prof Jean-Pascal Machiels - Cliniques Universitaires Sain-Luc, Brussels, Belgium )
11 Sep 2022
Tislelizumab OS benefit vs sorafenib as first line treatment for unresectable he...
Prof Richard S Finn - UCLA Health Santa Monica Cancer Care, Santa Monica, USA
Tislelizumab OS benefit vs sorafenib as first line treatment for unresectable hepatocellular carcinoma ( Prof Richard S Finn - UCLA Health Santa Monica Cancer Care, Santa Monica, USA )
11 Sep 2022
Hyperthermic intraperitoneal chemo for locally advanced colon cancer
Dr Álvaro Arjona-Sánchez- Reina Sofia University Hospital, Cordoba, Spain
Hyperthermic intraperitoneal chemo for locally advanced colon cancer ( Dr Álvaro Arjona-Sánchez- Reina Sofia University Hospital, Cordoba, Spain )
11 Sep 2022
Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and...
Prof Hope Rugo - UCSF Helen Diller Family Comprehensive Cancer Center, San Franc...
Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and QoL update ( Prof Hope Rugo - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA )
11 Sep 2022
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, US...
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Sep 2022
Scientists discover mechanism of action and an actionable inflammatory axis for ...
Prof Charles Swanton - The Francis Crick Institute, London, UK
Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC ( Prof Charles Swanton - The Francis Crick Institute, London, UK )
10 Sep 2022
How air pollution may trigger lung cancer in never-smokers
Prof Charles Swanton - Francis Crick Institute, London, England
How air pollution may trigger lung cancer in never-smokers ( Prof Charles Swanton - Francis Crick Institute, London, England )
10 Sep 2022
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Tumour-infiltrating lymphocyte treatment for advanced melanoma ( Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2022
Nirogacestat success for desmoid tumours
Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany
Nirogacestat success for desmoid tumours ( Dr Bernd Kasper -  Universitätsmedizin Mannheim, Mannheim, Germany )
10 Sep 2022
Global obstacles to lung cancer screening: Report
Professor Rudolf Huber - The Hospital of the University of Munich, Munich, Germ...
Global obstacles to lung cancer screening: Report ( Professor Rudolf Huber - The Hospital of the University of Munich,  Munich, Germany )
11 Aug 2022
IASLC Early Detection and Screening Committee: Global obstacles to lung cancer s...
Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serb...
IASLC Early Detection and Screening Committee: Global obstacles to lung cancer screening ( Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serbia )
11 Aug 2022
Personalised smoking cessation support in a lung cancer screening programme
Dr Rachael Murray - The University of Nottingham, Nottingham, UK
Personalised smoking cessation support in a lung cancer screening programme ( Dr Rachael Murray - The University of Nottingham, Nottingham, UK )
11 Aug 2022